Genetic animal models of cerebral vasculopathies

Progress in Molecular Biology and Translational Science

Volumn 105, Issue , 2012, Pages 25-55

  Lee, Jeong Hyun ^a   Bacskai, Brian J ^a   Ayata, Cenk ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82655181660     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394596-9.00002-0     Document Type: Chapter

References (197)

1. H.V. Vinters Cerebral amyloid angiopathy. A critical review Stroke 18 1987 311 324 (Pubitemid 17059655)
2. M. Yamada Cerebral amyloid angiopathy: an overview Neuropathology 20 2000 8 22 (Pubitemid 30312572)
3. K.A. Jellinger Alzheimer disease and cerebrovascular pathology: an update J Neural Transm 109 2002 813 836 (Pubitemid 34810776)
4. M. Kawai, R.N. Kalaria, P. Cras, S.L. Siedlak, M.E. Velasco, and E.R. Shelton Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease Brain Res 623 1993 142 146 (Pubitemid 23267401)
5. F. Gray, F. Dubas, E. Roullet, and R. Escourolle Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy Ann Neurol 18 1985 54 59 (Pubitemid 15025414)
6. J. Attems, M. Quass, K.A. Jellinger, and F. Lintner Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology J Neurol Sci 257 2007 49 55 (Pubitemid 46856485)
7. S.M. Greenberg, J.P. Vonsattel, J.W. Stakes, M. Gruber, and S.P. Finklestein The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage Neurology 43 1993 2073 2079 (Pubitemid 23318883)
8. Z. Arvanitakis, S.E. Leurgans, Z. Wang, R.S. Wilson, D.A. Bennett, and J.A. Schneider Cerebral amyloid angiopathy pathology and cognitive domains in older persons Ann Neurol 69 2011 320 327
9. C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease Nat Rev Neurosci 5 2004 347 360 (Pubitemid 38568496)
10. E.E. Smith, M. Vijayappa, F. Lima, P. Delgado, L. Wendell, and J. Rosand Impaired visual evoked flow velocity response in cerebral amyloid angiopathy Neurology 71 2008 1424 1430
11. C.I. Linde, S.G. Baryshnikov, A. Mazzocco-Spezzia, and V.A. Golovina Dysregulation of Ca2 + signaling in astrocytes from mice lacking amyloid precursor protein Am J Physiol Cell Physiol 300 2011 C1502 C1512
12. E.A. Milward, R. Papadopoulos, S.J. Fuller, R.D. Moir, D. Small, and K. Beyreuther The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth Neuron 9 1992 129 137
13. T. Okamoto, S. Takeda, Y. Murayama, E. Ogata, and I. Nishimoto Ligand-dependent G protein coupling function of amyloid transmembrane precursor J Biol Chem 270 1995 4205 4208
14. C. Priller, T. Bauer, G. Mitteregger, B. Krebs, H.A. Kretzschmar, and J. Herms Synapse formation and function is modulated by the amyloid precursor protein J Neurosci 26 2006 7212 7221
15. D. Schubert, L.W. Jin, T. Saitoh, and G. Cole The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion Neuron 3 1989 689 694
16. Z. Wang, B. Wang, L. Yang, Q. Guo, N. Aithmitti, and Z. Songyang Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis J Neurosci 29 2009 10788 10801
17. M.G. Belza, and H. Urich Cerebral amyloid angiopathy in Down's syndrome Clin Neuropathol 5 1986 257 260 (Pubitemid 17216117)
18. D.R. Thal, E. Ghebremedhin, U. Rub, H. Yamaguchi, K. Del Tredici, and H. Braak Two types of sporadic cerebral amyloid angiopathy J Neuropathol Exp Neurol 61 2002 282 293 (Pubitemid 34212603)
19. K. Oshima, H. Akiyama, K. Tsuchiya, H. Kondo, C. Haga, and Y. Shimomura Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology Acta Neuropathol 111 2006 510 518 (Pubitemid 43778955)
20. E. Levy, M.D. Carman, I.J. Fernandez-Madrid, M.D. Power, I. Lieberburg, and S.G. van Duinen Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type Science 248 1990 1124 1126
21. C. Van Broeckhoven, J. Haan, E. Bakker, J.A. Hardy, W. Van Hul, and A. Wehnert Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch) Science 248 1990 1120 1122 (Pubitemid 20189867)
22. M.C. Herzig, D.T. Winkler, P. Burgermeister, M. Pfeifer, E. Kohler, and S.D. Schmidt Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis Nat Neurosci 7 2004 954 960 (Pubitemid 39129504)
23. M.L. Maat-Schieman, H. Yamaguchi, S.G. van Duinen, R. Natte, and R.A. Roos Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis Acta Neuropathol 99 2000 409 419 (Pubitemid 30179580)
24. O. Bugiani, G. Giaccone, G. Rossi, M. Mangieri, R. Capobianco, and M. Morbin Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP Arch Neurol 67 2010 987 995
25. L. Hendriks, C.M. van Duijn, P. Cras, M. Cruts, W. Van Hul, and F. van Harskamp Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene Nat Genet 1 1992 218 221
26. S. Kumar-Singh, P. Cras, R. Wang, J.M. Kros, J. van Swieten, and U. Lubke Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric Am J Pathol 161 2002 507 520 (Pubitemid 36142160)
27. G. Roks, F. Van Harskamp, I. De Koning, M. Cruts, C. De Jonghe, and S. Kumar-Singh Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692) Brain 123 Pt 10 2000 2130 2140
28. T.J. Grabowski, H.S. Cho, J.P. Vonsattel, G.W. Rebeck, and S.M. Greenberg Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy Ann Neurol 49 2001 697 705 (Pubitemid 32530235)
29. S.M. Greenberg, Y. Shin, T.J. Grabowski, G.E. Cooper, G.W. Rebeck, and S. Iglesias Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation Neurology 60 2003 1020 1022 (Pubitemid 36348940)
30. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, and C. Forsell The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation Nat Neurosci 4 2001 887 893 (Pubitemid 32801591)
31. H. Basun, N. Bogdanovic, M. Ingelsson, O. Almkvist, J. Naslund, and K. Axelman Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease Arch Neurol 65 2008 499 505 (Pubitemid 351549959)
32. S.X. Zhang-Nunes, M.L. Maat-Schieman, S.G. van Duinen, R.A. Roos, M.P. Frosch, and S.M. Greenberg The cerebral beta-amyloid angiopathies: hereditary and sporadic Brain Pathol 16 2006 30 39
33. J. Davis, and W.E. Van Nostrand Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein Proc Natl Acad Sci USA 93 1996 2996 3000 (Pubitemid 26114352)
34. A.S. Johansson, F. Berglind-Dehlin, G. Karlsson, K. Edwards, P. Gellerfors, and L. Lannfelt Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt FEBS J 273 2006 2618 2630
35. J.P. Melchor, L. McVoy, and W.E. Van Nostrand Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein J Neurochem 74 2000 2209 2212 (Pubitemid 30217679)
36. W.E. Van Nostrand, J.P. Melchor, H.S. Cho, S.M. Greenberg, and G.W. Rebeck Pathogenic effects of D23N Iowa mutant amyloid beta-protein J Biol Chem 276 2001 32860 32866
37. M. Citron, T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, and P. Seubert Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production Nature 360 1992 672 674 (Pubitemid 23007680)
38. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706 (Pubitemid 21912142)
39. M. Mullan, F. Crawford, K. Axelman, H. Houlden, L. Lilius, and B. Winblad A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid Nat Genet 1 1992 345 347
40. J. Murrell, M. Farlow, B. Ghetti, and M.D. Benson A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease Science 254 1991 97 99 (Pubitemid 21917324)
41. A.A. Rensink, R.M. de Waal, B. Kremer, and M.M. Verbeek Pathogenesis of cerebral amyloid angiopathy Brain Res Brain Res Rev 43 2003 207 223 (Pubitemid 37315654)
42. L. Cabrejo, L. Guyant-Marechal, A. Laquerriere, M. Vercelletto, F. De la Fourniere, and C. Thomas-Anterion Phenotype associated with APP duplication in five families Brain 129 2006 2966 2976 (Pubitemid 44684517)
43. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
44. M.A. Chishti, D.S. Yang, C. Janus, A.L. Phinney, P. Horne, and J. Pearson Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J Biol Chem 276 2001 21562 21570 (Pubitemid 37413154)
45. D.M. Mann, S.M. Pickering-Brown, A. Takeuchi, and T. Iwatsubo Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease Am J Pathol 158 2001 2165 2175 (Pubitemid 32545202)
46. D. Nochlin, T.D. Bird, E.J. Nemens, M.J. Ball, and S.M. Sumi Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I) Ann Neurol 43 1998 131 135 (Pubitemid 28124661)
47. H. Steiner, T. Revesz, M. Neumann, H. Romig, M.G. Grim, and B. Pesold A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques J Biol Chem 276 2001 7233 7239
48. B. Ghetti, P. Piccardo, M.G. Spillantini, Y. Ichimiya, M. Porro, and F. Perini Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP Proc Natl Acad Sci USA 93 1996 744 748 (Pubitemid 26041161)
49. E. Levy, M. Haltia, I. Fernandez-Madrid, O. Koivunen, J. Ghiso, and F. Prelli Mutation in gelsolin gene in Finnish hereditary amyloidosis J Exp Med 172 1990 1865 1867
50. A. Palsdottir, A.O. Snorradottir, and L. Thorsteinsson Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects Brain Pathol 16 2006 55 59
51. R.B. Petersen, H. Goren, M. Cohen, S.L. Richardson, N. Tresser, and A. Lynn Transthyretin amyloidosis: a new mutation associated with dementia Ann Neurol 41 1997 307 313 (Pubitemid 27114041)
52. R. Vidal, B. Frangione, A. Rostagno, S. Mead, T. Revesz, and G. Plant A stop-codon mutation in the BRI gene associated with familial British dementia Nature 399 1999 776 781 (Pubitemid 29293172)
53. R. Vidal, T. Revesz, A. Rostagno, E. Kim, J.L. Holton, and T. Bek A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred Proc Natl Acad Sci USA 97 2000 4920 4925 (Pubitemid 30238658)
54. L.C. Walker Animal models of cerebral beta-amyloid angiopathy Brain Res Brain Res Rev 25 1997 70 84 (Pubitemid 27459721)
55. J.D. Fryer, J.W. Taylor, R.B. DeMattos, K.R. Bales, S.M. Paul, and M. Parsadanian Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice J Neurosci 23 2003 7889 7896 (Pubitemid 37052357)
56. R.E. Hartman, Y. Izumi, K.R. Bales, S.M. Paul, D.F. Wozniak, and D.M. Holtzman Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease J Neurosci 25 2005 6213 6220 (Pubitemid 40923488)
57. K.R. Bales, T. Verina, R.C. Dodel, Y. Du, L. Altstiel, and M. Bender Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat Genet 17 1997 263 264
58. M.M. Racke, L.I. Boone, D.L. Hepburn, M. Parsadainian, M.T. Bryan, and D.K. Ness Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta J Neurosci 25 2005 629 636
59. E. Masliah, A. Sisk, M. Mallory, L. Mucke, D. Schenk, and D. Games Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease J Neurosci 16 1996 5795 5811 (Pubitemid 26293401)
60. M.C. Irizarry, F. Soriano, M. McNamara, K.J. Page, D. Schenk, and D. Games Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse J Neurosci 17 1997 7053 7059 (Pubitemid 27427884)
61. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, and C. Blackwell Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373 1995 523 527
62. M.A. Westerman, D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi, and L.H. Younkin The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease J Neurosci 22 2002 1858 1867 (Pubitemid 35386304)
63. J.S. Jacobsen, C.C. Wu, J.M. Redwine, T.A. Comery, R. Arias, and M. Bowlby Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease Proc Natl Acad Sci USA 103 2006 5161 5166
64. H.K. Shin, P.B. Jones, M. Garcia-Alloza, L. Borrelli, S.M. Greenberg, and B.J. Bacskai Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy Brain 130 2007 2310 2319 (Pubitemid 47327629)
65. M.C. Irizarry, M. McNamara, K. Fedorchak, K. Hsiao, and B.T. Hyman APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1 J Neuropathol Exp Neurol 56 1997 965 973 (Pubitemid 27386126)
66. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, and S. Younkin Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102 (Pubitemid 26332733)
67. B.H. Han, M.L. Zhou, F. Abousaleh, R.P. Brendza, H.H. Dietrich, and J. Koenigsknecht-Talboo Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition J Neurosci 28 2008 13542 13550
68. M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller, and M. Staufenbiel Cerebral hemorrhage after passive anti-Abeta immunotherapy Science 298 2002 1379 (Pubitemid 35346131)
69. D.T. Winkler, L. Bondolfi, M.C. Herzig, L. Jann, M.E. Calhoun, and K.H. Wiederhold Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy J Neurosci 21 2001 1619 1627 (Pubitemid 32182202)
70. D.T. Winkler, L. Biedermann, M. Tolnay, P.R. Allegrini, M. Staufenbiel, and C. Wiessner Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy Ann Neurol 51 2002 790 793 (Pubitemid 34568863)
71. D. Van Dam, R. D'Hooge, M. Staufenbiel, C. Van Ginneken, F. Van Meir, and P.P. De Deyn Age-dependent cognitive decline in the APP23 model precedes amyloid deposition Eur J Neurosci 17 2003 388 396 (Pubitemid 36459519)
72. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, and S. Rothacher Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc Natl Acad Sci USA 94 1997 13287 13292 (Pubitemid 27518514)
73. P.H. Kelly, L. Bondolfi, D. Hunziker, H.P. Schlecht, K. Carver, and E. Maguire Progressive age-related impairment of cognitive behavior in APP23 transgenic mice Neurobiol Aging 24 2003 365 378 (Pubitemid 36005416)
74. M.E. Calhoun, P. Burgermeister, A.L. Phinney, M. Stalder, M. Tolnay, and K.H. Wiederhold Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid Proc Natl Acad Sci USA 96 1999 14088 14093
75. D. Moechars, I. Dewachter, K. Lorent, D. Reverse, V. Baekelandt, and A. Naidu Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain J Biol Chem 274 1999 6483 6492 (Pubitemid 29111064)
76. J. Van Dorpe, L. Smeijers, I. Dewachter, D. Nuyens, K. Spittaels, and C. Van Den Haute Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons Am J Pathol 157 2000 1283 1298
77. S. Dudal, P. Krzywkowski, J. Paquette, C. Morissette, D. Lacombe, and P. Tremblay Inflammation occurs early during the Abeta deposition process in TgCRND8 mice Neurobiol Aging 25 2004 861 871 (Pubitemid 38813166)
78. C.A. Hawkes, and J. McLaurin Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy Proc Natl Acad Sci USA 106 2009 1261 1266
79. J. Davis, F. Xu, R. Deane, G. Romanov, M.L. Previti, and K. Zeigler Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor J Biol Chem 279 2004 20296 20306 (Pubitemid 38623475)
80. J. Miao, F. Xu, J. Davis, I. Otte-Holler, M.M. Verbeek, and W.E. Van Nostrand Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein Am J Pathol 167 2005 505 515 (Pubitemid 43026105)
81. F. Xu, A.M. Grande, J.K. Robinson, M.L. Previti, M. Vasek, and J. Davis Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice Neuroscience 146 2007 98 107 (Pubitemid 46654629)
82. M.C. Herzig, W.E. Van Nostrand, and M. Jucker Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models Brain Pathol 16 2006 40 54
83. D.M. Wilcock, M.R. Lewis, W.E. Van Nostrand, J. Davis, M.L. Previti, and N. Gharkholonarehe Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2 J Neurosci 28 2008 1537 1545 (Pubitemid 351287042)
84. A. Lord, H. Kalimo, C. Eckman, X.Q. Zhang, L. Lannfelt, and L.N. Nilsson The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice Neurobiol Aging 27 2006 67 77 (Pubitemid 41627951)
85. M. Knobloch, U. Konietzko, D.C. Krebs, and R.M. Nitsch Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice Neurobiol Aging 28 2007 1297 1306 (Pubitemid 47081235)
86. F.L. Princz-Kranz, T. Mueggler, M. Knobloch, R.M. Nitsch, and M. Rudin Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis Neurobiol Dis 40 2010 284 292
87. J. Davis-Salinas, S.M. Saporito-Irwin, C.W. Cotman, and W.E. Van Nostrand Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells J Neurochem 65 1995 931 934
88. J. Frackowiak, D.L. Miller, A. Potempska, T. Sukontasup, and B. Mazur-Kolecka Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice J Neuropathol Exp Neurol 62 2003 685 696 (Pubitemid 36682641)
89. J. Frackowiak, A. Potempska, H. LeVine, T. Haske, D. Dickson, and B. Mazur-Kolecka Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells J Neuropathol Exp Neurol 64 2005 82 90 (Pubitemid 40189482)
90. H.M. Wisniewski, J. Frackowiak, and B. Mazur-Kolecka In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels Neurosci Lett 183 1995 120 123
91. M.M. Verbeek, R.M. de Waal, J.J. Schipper, and W.E. Van Nostrand Rapid degeneration of cultured human brain pericytes by amyloid beta protein J Neurochem 68 1997 1135 1141 (Pubitemid 27086218)
92. R.N. Kalaria, D.R. Premkumar, A.B. Pax, D.L. Cohen, and I. Lieberburg Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease Brain Res Mol Brain Res 35 1996 58 68 (Pubitemid 26036732)
93. R. Natte, W.I. de Boer, M.L. Maat-Schieman, H.J. Baelde, H.V. Vinters, and R.A. Roos Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls Brain Res 828 1999 179 183 (Pubitemid 29236490)
94. K. Fukuchi, L. Ho, S.G. Younkin, D.D. Kunkel, C.E. Ogburn, and R.C. LeBoeuf High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice Am J Pathol 149 1996 219 227 (Pubitemid 26230993)
95. H. Yamaguchi, T. Yamazaki, C.A. Lemere, M.P. Frosch, and D.J. Selkoe Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study Am J Pathol 141 1992 249 259
96. R.O. Weller, A. Massey, T.A. Newman, M. Hutchings, Y.M. Kuo, and A.E. Roher Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease Am J Pathol 153 1998 725 733 (Pubitemid 28419027)
97. P. Burgermeister, M.E. Calhoun, D.T. Winkler, and M. Jucker Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models Ann N Y Acad Sci 903 2000 307 316 (Pubitemid 30251571)
98. R.O. Weller, M. Subash, S.D. Preston, I. Mazanti, and R.O. Carare Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease Brain Pathol 18 2008 253 266 (Pubitemid 351430402)
99. R.O. Carare, M. Bernardes-Silva, T.A. Newman, A.M. Page, J.A. Nicoll, and V.H. Perry Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology Neuropathol Appl Neurobiol 34 2008 131 144 (Pubitemid 351327967)
100. I. Dewachter, D. Reverse, N. Caluwaerts, L. Ris, C. Kuiperi, and C. Van den Haute Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice J Neurosci 22 2002 3445 3453 (Pubitemid 37465750)
101. C.A. Hawkes, W. Hartig, J. Kacza, R. Schliebs, R.O. Weller, and J.A. Nicoll Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy Acta Neuropathol 121 2011 431 443
102. J. Attems, F. Lintner, and K.A. Jellinger Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology Acta Neuropathol 107 2004 283 291 (Pubitemid 38477354)
103. T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, and Y. Ihara Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43) Neuron 13 1994 45 53
104. N. Suzuki, T. Iwatsubo, A. Odaka, Y. Ishibashi, C. Kitada, and Y. Ihara High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy Am J Pathol 145 1994 452 460 (Pubitemid 24245845)
105. E. McGowan, F. Pickford, J. Kim, L. Onstead, J. Eriksen, and C. Yu Abeta42 is essential for parenchymal and vascular amyloid deposition in mice Neuron 47 2005 191 199 (Pubitemid 41019251)
106. C. De Jonghe, P. Cras, H. Vanderstichele, M. Cruts, I. Vanderhoeven, and I. Smouts Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype Neurobiol Dis 6 1999 280 287 (Pubitemid 29470039)
107. J. Kim, L. Onstead, S. Randle, R. Price, L. Smithson, and C. Zwizinski Abeta40 inhibits amyloid deposition in vivo J Neurosci 27 2007 627 633 (Pubitemid 46143766)
108. C. Janus, J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, and S.D. Schmidt A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982 (Pubitemid 32101644)
109. K.A. DaSilva, M.E. Brown, and J. McLaurin Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine Vaccine 27 2009 1365 1376
110. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, and E. Hosoki Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nat Med 6 2000 143 150 (Pubitemid 30082357)
111. I.V. Kurochkin, and S. Goto Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Lett 345 1994 33 37
112. E.A. Eckman, D.K. Reed, and C.B. Eckman Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme J Biol Chem 276 2001 24540 24548
113. D.G. Cook, J.B. Leverenz, P.J. McMillan, J.J. Kulstad, S. Ericksen, and R.A. Roth Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele Am J Pathol 162 2003 313 319 (Pubitemid 36042013)
114. J.S. Miners, Z. Van Helmond, K. Chalmers, G. Wilcock, S. Love, and P.G. Kehoe Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy J Neuropathol Exp Neurol 65 2006 1012 1021 (Pubitemid 44521802)
115. H. Kanemitsu, T. Tomiyama, and H. Mori Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form Neurosci Lett 350 2003 113 116 (Pubitemid 37101425)
116. M.A. Leissring, W. Farris, A.Y. Chang, D.M. Walsh, X. Wu, and X. Sun Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093 (Pubitemid 38032786)
117. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, and N.P. Gerard Metabolic regulation of brain Abeta by neprilysin Science 292 2001 1550 1552 (Pubitemid 32493424)
118. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 2003 4162 4167 (Pubitemid 36418174)
119. R. Deane, Z. Wu, A. Sagare, J. Davis, S. Du Yan, and K. Hamm LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms Neuron 43 2004 333 344 (Pubitemid 39061126)
120. M. Shibata, S. Yamada, S.R. Kumar, M. Calero, J. Bading, and B. Frangione Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J Clin Invest 106 2000 1489 1499 (Pubitemid 32038587)
121. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, and E. Hogg RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat Med 9 2003 907 913 (Pubitemid 36889934)
122. N. Durany, R. Ravid, P. Riederer, and F.F. Cruz-Sanchez Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy Neuropathology 20 2000 184 189 (Pubitemid 32963615)
123. M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, and M. Matsushita Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy Ann Neurol 44 1998 129 131 (Pubitemid 28323663)
124. M. Yamada, N. Sodeyama, Y. Itoh, A. Takahashi, E. Otomo, and M. Matsushita Association of neprilysin polymorphism with cerebral amyloid angiopathy J Neurol Neurosurg Psychiatry 74 2003 749 751 (Pubitemid 36628287)
125. T. Hamaguchi, S. Okino, N. Sodeyama, Y. Itoh, A. Takahashi, and E. Otomo Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy J Neurol Neurosurg Psychiatry 76 2005 696 699 (Pubitemid 40569681)
126. M. Christoforidis, R. Schober, and K. Krohn Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy Neuropathol Appl Neurobiol 31 2005 11 19 (Pubitemid 40222821)
127. P.B. Verghese, J.M. Castellano, and D.M. Holtzman Apolipoprotein E in Alzheimer's disease and other neurological disorders Lancet Neurol 10 2011 241 252
128. D.C. Rubinsztein Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease Psychol Med 25 1995 223 229
129. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923 (Pubitemid 23275809)
130. S.M. Greenberg, G.W. Rebeck, J.P. Vonsattel, T. Gomez-Isla, and B.T. Hyman Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy Ann Neurol 38 1995 254 259
131. D.R. Premkumar, D.L. Cohen, P. Hedera, R.P. Friedland, and R.N. Kalaria Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease Am J Pathol 148 1996 2083 2095
132. S.M. Greenberg, J.P. Vonsattel, A.Z. Segal, R.I. Chiu, A.E. Clatworthy, and A. Liao Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy Neurology 50 1998 961 965 (Pubitemid 28212822)
133. M.O. McCarron, and J.A. Nicoll Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage Ann N Y Acad Sci 903 2000 176 179 (Pubitemid 30251556)
134. J.A. Nicoll, C. Burnett, S. Love, D.I. Graham, D. Dewar, and J.W. Ironside High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy Ann Neurol 41 1997 716 721 (Pubitemid 27249176)
135. E.H. Corder, A.M. Saunders, N.J. Risch, W.J. Strittmatter, D.E. Schmechel, and P.C. Gaskell Jr. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Nat Genet 7 1994 180 184 (Pubitemid 24174658)
136. D.M. Holtzman, A.M. Fagan, B. Mackey, T. Tenkova, L. Sartorius, and S.M. Paul Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model Ann Neurol 47 2000 739 747 (Pubitemid 30390194)
137. C. Iadecola, F. Zhang, K. Niwa, C. Eckman, S.K. Turner, and E. Fischer SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid
138. K. Niwa, G.A. Carlson, and C. Iadecola Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice J Cereb Blood Flow Metab 20 2000 1659 1668
139. K. Niwa, K. Kazama, L. Younkin, S.G. Younkin, G.A. Carlson, and C. Iadecola Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein Am J Physiol Heart Circ Physiol 283 2002 H315 H323
140. L. Park, J. Anrather, C. Forster, K. Kazama, G.A. Carlson, and C. Iadecola Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex J Cereb Blood Flow Metab 24 2004 334 342 (Pubitemid 38314589)
141. T. Mueggler, C. Sturchler-Pierrat, D. Baumann, M. Rausch, M. Staufenbiel, and M. Rudin Compromised hemodynamic response in amyloid precursor protein transgenic mice J Neurosci 22 2002 7218 7224 (Pubitemid 35379175)
142. A. Joutel, C. Corpechot, A. Ducros, K. Vahedi, H. Chabriat, and P. Mouton Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia Nature 383 1996 707 710 (Pubitemid 26360644)
143. H. Chabriat, A. Joutel, M. Dichgans, E. Tournier-Lasserve, and M.G. Bousser Cadasil Lancet Neurol 8 2009 643 653
144. E. Tournier-Lasserve, A. Joutel, J. Melki, J. Weissenbach, G.M. Lathrop, and H. Chabriat Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12 Nat Genet 3 1993 256 259 (Pubitemid 23096563)
145. Y. Dong, A. Hassan, Z. Zhang, D. Huber, C. Dalageorgou, and H.S. Markus Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis Stroke 34 2003 203 205 (Pubitemid 36070823)
146. S. Singhal, S. Bevan, T. Barrick, P. Rich, and H.S. Markus The influence of genetic and cardiovascular risk factors on the CADASIL phenotype Brain 127 2004 2031 2038 (Pubitemid 39150261)
147. M.K. Liem, J. van der Grond, J. Haan, R. van den Boom, M.D. Ferrari, and Y.M. Knaap Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL Stroke 38 2007 923 928 (Pubitemid 46568454)
148. A. Viswanathan, A. Gschwendtner, J.P. Guichard, F. Buffon, R. Cumurciuc, and M. O'Sullivan Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL Neurology 69 2007 172 179 (Pubitemid 47051722)
149. S. Tikka, K. Mykkanen, M.M. Ruchoux, R. Bergholm, M. Junna, and M. Poyhonen Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients Brain 132 2009 933 939
150. R. Okeda, K. Arima, and M. Kawai Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case Stroke 33 2002 2565 2569 (Pubitemid 35266424)
151. Y. Yamamoto, M. Ihara, C. Tham, R.W. Low, J.Y. Slade, and T. Moss Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL Stroke 40 2009 2004 2011
152. Q. Miao, T. Paloneva, S. Tuominen, M. Poyhonen, S. Tuisku, and M. Viitanen Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Brain Pathol 14 2004 358 364 (Pubitemid 39524964)
153. V. Domenga, P. Fardoux, P. Lacombe, M. Monet, J. Maciazek, and L.T. Krebs Notch3 is required for arterial identity and maturation of vascular smooth muscle cells Genes Dev 18 2004 2730 2735 (Pubitemid 39507766)
154. T. Wang, M. Baron, and D. Trump An overview of Notch3 function in vascular smooth muscle cells Prog Biophys Mol Biol 96 2008 499 509 (Pubitemid 351635621)
155. R. Bruening, M. Dichgans, C. Berchtenbreiter, T. Yousry, K.C. Seelos, and R.H. Wu Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance AJNR Am J Neuroradiol 22 2001 1268 1274 (Pubitemid 32734797)
156. H. Chabriat, S. Pappata, L. Ostergaard, C.A. Clark, M. Pachot-Clouard, and K. Vahedi Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking Stroke 31 2000 1904 1912 (Pubitemid 30620471)
157. T. Pfefferkorn, S. von Stuckrad-Barre, J. Herzog, T. Gasser, G.F. Hamann, and M. Dichgans Reduced cerebrovascular CO(2) reactivity in CADASIL: a transcranial Doppler sonography study Stroke 32 2001 17 21 (Pubitemid 32063818)
158. S. Tuominen, Q. Miao, T. Kurki, S. Tuisku, M. Poyhonen, and H. Kalimo Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients Stroke 35 2004 1063 1067 (Pubitemid 38543518)
159. R. van den Boom, S.A. Lesnik Oberstein, A. Spilt, F. Behloul, M.D. Ferrari, and J. Haan Cerebral hemodynamics and white matter hyperintensities in CADASIL J Cereb Blood Flow Metab 23 2003 599 604 (Pubitemid 36566136)
160. N. Peters, T. Freilinger, C. Opherk, T. Pfefferkorn, and M. Dichgans Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL J Neurol 255 2008 1203 1208
161. M.M. Ruchoux, and C.A. Maurage Endothelial changes in muscle and skin biopsies in patients with CADASIL Neuropathol Appl Neurobiol 24 1998 60 65
162. A. Stenborg, H. Kalimo, M. Viitanen, A. Terent, and L. Lind Impaired endothelial function of forearm resistance arteries in CADASIL patients Stroke 38 2007 2692 2697 (Pubitemid 47494005)
163. J.C. Choi, S.Y. Kang, J.H. Kang, and J.K. Park Intracerebral hemorrhages in CADASIL Neurology 67 2006 2042 2044 (Pubitemid 44967387)
164. A. Joutel, D.D. Dodick, J.E. Parisi, M. Cecillon, E. Tournier-Lasserve, and M.G. Bousser De novo mutation in the Notch3 gene causing CADASIL Ann Neurol 47 2000 388 391 (Pubitemid 30141853)
165. E. Coto, M. Menendez, R. Navarro, M. Garcia-Castro, and V. Alvarez A new de novo Notch3 mutation causing CADASIL Eur J Neurol 13 2006 628 631 (Pubitemid 43873635)
166. A. Joutel, F. Andreux, S. Gaulis, V. Domenga, M. Cecillon, and N. Battail The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients J Clin Invest 105 2000 597 605 (Pubitemid 30146506)
167. A. Joutel, M. Monet-Lepretre, C. Gosele, C. Baron-Menguy, A. Hammes, and S. Schmidt Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease J Clin Invest 120 2010 433 445
168. S. Artavanis-Tsakonas, M.D. Rand, and R.J. Lake Notch signaling: cell fate control and signal integration in development Science 284 1999 770 776 (Pubitemid 29291335)
169. B. D'Souza, A. Miyamoto, and G. Weinmaster The many facets of Notch ligands Oncogene 27 2008 5148 5167
170. A. Joutel, K. Vahedi, C. Corpechot, A. Troesch, H. Chabriat, and C. Vayssiere Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients Lancet 350 1997 1511 1515 (Pubitemid 28036555)
171. N. Peters, C. Opherk, T. Bergmann, M. Castro, J. Herzog, and M. Dichgans Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies Arch Neurol 62 2005 1091 1094 (Pubitemid 41043729)
172. M. Dichgans, H. Ludwig, J. Muller-Hocker, A. Messerschmidt, and T. Gasser Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains Eur J Hum Genet 8 2000 280 285 (Pubitemid 30336181)
173. C.P. Donahue, and K.S. Kosik Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL Genomics 83 2004 59 65 (Pubitemid 37518260)
174. C. Opherk, M. Duering, N. Peters, A. Karpinska, S. Rosner, and E. Schneider CADASIL mutations enhance spontaneous multimerization of NOTCH3 Hum Mol Genet 18 2009 2761 2767
175. A. Joutel, M. Monet, V. Domenga, F. Riant, and E. Tournier-Lasserve Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway Am J Hum Genet 74 2004 338 347 (Pubitemid 38168621)
176. N. Peters, C. Opherk, S. Zacherle, A. Capell, P. Gempel, and M. Dichgans CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk Exp Cell Res 299 2004 454 464 (Pubitemid 39179811)
177. M. Dichgans, M. Filippi, R. Bruning, G. Iannucci, C. Berchtenbreiter, and L. Minicucci Quantitative MRI in CADASIL: correlation with disability and cognitive performance Neurology 52 1999 1361 1367 (Pubitemid 29190524)
178. M. Dichgans, M. Mayer, I. Uttner, R. Bruning, J. Muller-Hocker, and G. Rungger The phenotypic spectrum of CADASIL: clinical findings in 102 cases Ann Neurol 44 1998 731 739 (Pubitemid 28516043)
179. J.F. Arboleda-Velasquez, F. Lopera, E. Lopez, M.P. Frosch, D. Sepulveda-Falla, and J.E. Gutierrez C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke Neurology 59 2002 277 279 (Pubitemid 34779191)
180. M. Monet-Lepretre, B. Bardot, B. Lemaire, V. Domenga, O. Godin, and M. Dichgans Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain Brain 132 2009 1601 1612
181. A. Joutel, H. Chabriat, K. Vahedi, V. Domenga, C. Vayssiere, and M.M. Ruchoux Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL Neurology 54 2000 1874 1875 (Pubitemid 30428427)
182. C. Opherk, N. Peters, J. Herzog, R. Luedtke, and M. Dichgans Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients Brain 127 2004 2533 2539 (Pubitemid 39472981)
183. J.F. Arboleda-Velasquez, Z. Zhou, H.K. Shin, A. Louvi, H.H. Kim, and S.I. Savitz Linking Notch signaling to ischemic stroke Proc Natl Acad Sci USA 105 2008 4856 4861 (Pubitemid 351753836)
184. E.J. Belin de Chantemele, K. Retailleau, F. Pinaud, E. Vessieres, A. Bocquet, and A.L. Guihot Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries Arterioscler Thromb Vasc Biol 28 2008 2216 2224
185. T. Kitamoto, K. Takahashi, H. Takimoto, K. Tomizuka, M. Hayasaka, and T. Tabira Functional redundancy of the Notch gene family during mouse embryogenesis: analysis of Notch gene expression in Notch3-deficient mice Biochem Biophys Res Commun 331 2005 1154 1162 (Pubitemid 40692479)
186. L.T. Krebs, Y. Xue, C.R. Norton, J.P. Sundberg, P. Beatus, and U. Lendahl Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation Genesis 37 2003 139 143 (Pubitemid 37486875)
187. C. Dubroca, P. Lacombe, V. Domenga, J. Maciazek, B. Levy, and E. Tournier-Lasserve Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy Stroke 36 2005 113 117 (Pubitemid 40054185)
188. P. Lacombe, C. Oligo, V. Domenga, E. Tournier-Lasserve, and A. Joutel Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy Stroke 36 2005 1053 1058 (Pubitemid 40629302)
189. M. Monet, V. Domenga, B. Lemaire, C. Souilhol, F. Langa, and C. Babinet The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo Hum Mol Genet 16 2007 982 992 (Pubitemid 47062741)
190. M.M. Ruchoux, V. Domenga, P. Brulin, J. Maciazek, S. Limol, and E. Tournier-Lasserve Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Am J Pathol 162 2003 329 342 (Pubitemid 36042015)
191. J. Lundkvist, S. Zhu, E.M. Hansson, P. Schweinhardt, Q. Miao, and P. Beatus Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype Genesis 41 2005 13 22 (Pubitemid 40269718)
192. J.F. Arboleda-Velasquez, J. Manent, J.H. Lee, S. Tikka, C. Ospina, and C.R. Vanderburg PNAS Plus: hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease Proc Natl Acad Sci USA 108 2011 E128 E135
193. C. Ayata CADASIL: experimental insights from animal models Stroke 41 2010 S129 S134
194. U. Utku, Y. Celik, O. Uyguner, M. Yuksel-Apak, and B. Wollnik CADASIL syndrome in a large Turkish kindred caused by the R90C mutation in the Notch3 receptor Eur J Neurol 9 2002 23 28
195. H. Karlstrom, P. Beatus, K. Dannaeus, G. Chapman, U. Lendahl, and J. Lundkvist A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling Proc Natl Acad Sci USA 99 2002 17119 17124 (Pubitemid 36034108)
196. K. Eikermann-Haerter, I. Yuzawa, E. Dilekoz, A. Joutel, M.A. Moskowitz, and C. Ayata Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression Ann Neurol 69 2011 413 418
197. C. Fouillade, H. Chabriat, F. Riant, M. Mine, M. Arnoud, and L. Magy Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain Hum Mutat 29 2008 452